The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for InnoVoyce sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
InnoVoyce is a voice health medical technology company. It develops and manufactures cutting-edge laser technology products to advance vocal health. The company develops and delivers advanced technologies, therapeutics and innovative solutions to preserve and restore the human voice. InnoVoyce’s products include KTP laser fibers for the treatment of cutting, vaporization, ablation and coagulation of soft tissue. Its products are used to improve voice and airway surgical procedures; diagnosis and detection of voice problems, and restoration of damaged vocal cords. InnoVoyce is headquartered in Boston, Massachusetts, the US.
The key metrics of InnoVoyce related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As InnoVoyce is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as InnoVoyce.
For a detailed understanding of the performance of InnoVoyce, buy the report here.